Cetuximab Completed Phase 1 Trials for Non-Small Cell Lung Carcinoma (NSCLC) / Colorectal Cancers / Head and Neck Carcinoma

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT00820417Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib